Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pembrolizumab, Trastuzumab, HER2 Positive Gastric Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02901301
Recruitment Status : Active, not recruiting
First Posted : September 15, 2016
Last Update Posted : January 14, 2020
Sponsor:
Information provided by (Responsible Party):
Hyun Cheol Chung, Yonsei University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : October 2020
Estimated Study Completion Date : October 2021